These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4180646)

  • 21. [On the treatment of chronic polyarthritis with cytostatic agents. I. Combined therapy with trenimon and proresid. Clinical and serological studies].
    Chlud K; Prohaska E; Pfaller C
    Z Rheumaforsch; 1967 Jun; 26(5):250-60. PubMed ID: 4878333
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antimitotic effect of podophyllin derivatives on genital cancers].
    Stamm O
    Bull Soc R Belge Gynecol Obstet; 1965; 35(4):287-90. PubMed ID: 5856818
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical observations and results of the treatment of malignant tumors with podophyllim derivatives Sp-I and Sp-G].
    Tomov V; Popov G; Stoianov E
    Khirurgiia (Sofiia); 1965; 18(6):623-32. PubMed ID: 5886870
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cytostatic and antimetabolite therapy in chronic inflammatory joint diseases and collagen diseases].
    Chlud K
    Munch Med Wochenschr; 1969 Aug; 111(32):1626-9. PubMed ID: 5394967
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors.
    Dombernowsky P; Nissen NI; Larsen V
    Cancer Chemother Rep; 1972 Feb; 56(1):71-82. PubMed ID: 4624138
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experience in the therapeutic use of podophyllin in some dermatoses].
    Popov IS; Chepyzhenko VV
    Vrach Delo; 1966 Jan; 1():150-1. PubMed ID: 5974047
    [No Abstract]   [Full Text] [Related]  

  • 27. The treatment of skin carcinoma with podophyllum derivatives.
    Bettley FR
    Br J Dermatol; 1971 Jan; 84(1):74-82. PubMed ID: 5573186
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical experiences with SP-I].
    Furue H; Koizumi H; Nishi I; Hattori T; Yokoyama T
    Gan No Rinsho; 1967 Sep; 13(9):658-62. PubMed ID: 5627165
    [No Abstract]   [Full Text] [Related]  

  • 29. [The treatment of primary chronic polyarthritis with immunosuppressive cytostatic podophyllin derivatives].
    Gömör B; Szántó L; Görgényi F; Benczur M; Ligetiné Reviczky A; Bányai B; Lörincz G
    Orv Hetil; 1969 Jan; 110(4):181-6. PubMed ID: 5779082
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cytostatic therapy of metastatic and advanced malignant tumors of the ENT region with podophyllin derivatives (SPI-SPG)].
    Lipozencić M; Padovan I
    Rad Med Fak Zagrebu; 1965; 13(1):57-67. PubMed ID: 5871944
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimental studies with Proresid in inoculated sarcoma of the mouse].
    Hilscher W; Ritzl F; Stockhausen W; Witt I
    Strahlentherapie; 1970 Oct; 140(4):460-2. PubMed ID: 5510464
    [No Abstract]   [Full Text] [Related]  

  • 32. [Favourable response of advanced ovarian cancer to treatment with a podophyllin derivative (SP-I and SP-G)].
    Tomin R
    Srp Arh Celok Lek; 1965 Oct; 93(10):973-9. PubMed ID: 5872509
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of immunosuppressive therapy with podophyllin derivatives in the treatment of primary chronic polyarthritis].
    Szántó L
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:154. PubMed ID: 5402573
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experiences with the cytostatic podophyllin therapy].
    Halama J
    Munch Med Wochenschr; 1967 Feb; 108(7):378-81. PubMed ID: 4862314
    [No Abstract]   [Full Text] [Related]  

  • 35. [The association of podophyllum derivatives and cyclophosphamide in the palliative therapy of female pelvic neoplasms].
    Varianti G
    Cancro; 1965; 18(6):526-41. PubMed ID: 4162232
    [No Abstract]   [Full Text] [Related]  

  • 36. [Submicroscopic changes in human cancer cells under the effect of SP-I and SP-G "Sandoz"].
    Sipus N; Padovan I; Lipozencić M
    Oncology; 1966; 20(4):276-90. PubMed ID: 5958475
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the effect of combined therapy with SP-I Sandoz and radiation in experimental sarcoma 37 in mice].
    Benz A
    Dermatologica; 1968; 136(5):368-82. PubMed ID: 5662281
    [No Abstract]   [Full Text] [Related]  

  • 38. [Problems in combined radio-cytostatic therapy. 7. Syncarcinolytic studies using 5-fluorouracil, natulan and proresid in Crocker sarcoma 180 of mice].
    Ringleb D; Krieg R; Sauer D
    Strahlentherapie; 1969 Oct; 138(4):423-8. PubMed ID: 5352491
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies of chemical sensitization in the radiotherapy of oral and cervical carcinomas.
    Krishnamurthi S; Shanta V; Nair MK
    Cancer; 1967 May; 20(5):822-5. PubMed ID: 5337396
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cancer of the esophagus - treatment by cytostatics SP-G and SP-I. Previous communication].
    Guida Filho B; Mirra AP
    Hospital (Rio J); 1967 Aug; 72(2):633-40. PubMed ID: 5302562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.